AI Chat Paper
Note: Please note that the following content is generated by AMiner AI. SciOpen does not take any responsibility related to this content.
{{lang === 'zh_CN' ? '文章概述' : 'Summary'}}
{{lang === 'en_US' ? '中' : 'Eng'}}
Chat more with AI
Powered by AMiner. Clicking this button will take you away from SciOpen.
Home Genes & Diseases Article
PDF (739 KB)
Cite
EndNote(RIS) BibTeX
Collect
Submit Manuscript AI Chat Paper
Show Outline
Outline
Show full outline
Hide outline
Outline
Show full outline
Hide outline
Rapid Communication | Open Access

A complex signature network that controls the upregulation of PRMT5 in colorectal cancer

Han Weia,d,1, Antja-Voy Hartleya,e,1, Aishat Motolania,1, Guanglong Jiangb, Ahmad Safaa, Lakshmi Prabhua,f, Yunlong Liub, Tao Lua,b,c( )
Department of Pharmacology and Toxicology, Indiana University School of Medicine, 635 Barnhill Drive, Indianapolis, IN 46202, USA
Department of Medical & Molecular Genetics, Indiana University School of Medicine, 975 W. Walnut Street, Indianapolis, IN 46202, USA
Department of Biochemistry and Molecular Biology, Indiana University School of Medicine, 635 Barnhill Drive, Indianapolis, IN 46202, USA
Current address: Beckman Coulter Life Sciences, 5350 Lakeview Pkwy S Dr, Indianapolis, IN 46268, USA
Current address: Dana-Farber Cancer Institute, Harvard Medical School, 450 Brookline Ave., Boston, MA 02215, USA
Current address: Gilead Sciences, Inc., 333 Lakeside Drive Foster City, CA 94404, USA

Peer review under responsibility of Chongqing Medical University.

1 These authors contributed to this work equally.

Show Author Information

References

1

Xiao W, Chen X, Liu L, Shu Y, Zhang M, Zhong Y. Role of protein arginine methyltransferase 5 in human cancers. Biomed Pharmacother. 2019;114: e108790.
Crossref Google Scholar
2

Prabhu L, Wei H, Chen L, et al. Adapting AlphaLISA high throughput screen to discover a novel small-molecule inhibitor targeting protein arginine methyltransferase 5 in pancreatic and colorectal cancers. Oncotarget. 2017;8(25): 39963-39977.
Crossref Google Scholar
3

Paek AR, Mun JY, Jo MJ, et al. The role of ZNF143 in breast cancer cell survival through the NAD(P)H quinone dehydrogenase 1-p53-beclin1 axis under metabolic stress. Cells. 2019;8(4): e296.
Crossref Google Scholar
4

Zhang HT, Zeng LF, He QY, Tao WA, Zha ZG, Hu CD. The E3 ubiquitin ligase CHIP mediates ubiquitination and proteasomal degradation of PRMT5. Biochim Biophys Acta. 2016;1863(2): 335-346.
Crossref Google Scholar
5

Dibrov A, Kashour T, Amara FM. The role of transforming growth factor beta signaling in messenger RNA stability. Growth Factors. 2006;24(1): 1-11.
Crossref Google Scholar
Genes & Diseases
Volume 9 Issue 2,
March 2022
Pages 285-287
DOI: 10.1016/j.gendis.2021.11.001
Cite this article:
Wei H, Hartley A-V, Motolani A, et al. A complex signature network that controls the upregulation of PRMT5 in colorectal cancer. Genes & Diseases, 2022, 9(2): 285-287. https://doi.org/10.1016/j.gendis.2021.11.001

322

Views

10

Downloads

1

Crossref

1

Web of Science

1

Scopus

0

CSCD

Altmetrics
Received: 17 September 2021
Published: 26 November 2021
© 2021, Chongqing Medical University. Production and hosting by Elsevier B.V.

This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
Return